OMOP Concept 37560903
Lenalidomide and Rituximab (R2) and Tafasitamab
StandardRegimenHemOnc136492Regimen
Maps from
0
Descendants
0
Valid from
26 Feb 2024
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(31)Roll up to these when you need a wider cohort.
- 1Anti-CD19 antibody-containing regimen
- 1Anti-CD20 antibody-containing regimen
- 1Immunomodulatory drugs (IMiDs)-containing regimen
- 1lenalidomide
- 1Lenalidomide-containing regimen
- 1Multiagent regimen
- 1rituximab
- 1Rituximab-containing regimen
- 1tafasitamab
- 1Tafasitamab-containing regimen
- 1Targeted therapy
- 1Targeted therapy-containing regimen
- 2Anti-CD19 antibody
- 2Anti-CD20 antibody
- 2Biosimilar
- 2Generic class-based regimen
- 2Immunomodulatory drugs (IMiDs)
- 2Light-chain (AL) amyloidosis medication
- 2Named class-based regimen
- 2Neutral
- 2REMS program
- 2WHO Essential Cancer Medicine
- 3Antineoplastic monoclonal antibody
- 3Drugs by local effect
- 3Immunosuppressive monoclonal antibody
Get this concept via the API
Resolve Lenalidomide and Rituximab (R2) and Tafasitamab - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/37560903?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card